Morgan Stanley PE acquires controlling stake in ClearMedi Healthcare

BENGALURU: Morgan Stanley PE Asia has acquired a controlling stake in ClearMedi Healthcare, a Delhi-headquartered chain of oncology hospitals and radiation remedy centres, in a deal valued at about $35 million (Rs 285 crore).

Italy’s KOS Group, which has been a strategic investor, exited ClearMedi by promoting its stake to the PE agency and the promoters of the healthcare supplier, individuals briefed on the transactions informed ET.

The deal additionally concerned an infusion of fairness into the corporate, the individuals stated. They didn’t disclose particular particulars, such because the proportion of stakes picked by the PE fund and the founders from the KOS Group, and the fund infusion within the firm.

Based in 2010 by Shashi Kant Baliyan, ClearMedi runs its amenities in eight states and a union territory.

Chennai-based funding bankers Advay Capital suggested the promoter group of Clearmedi and Morgan Stanley PE on the transaction.

Emails despatched to the KOS Group, ClearMedi, Morgan Stanley PE and Advay Capital didn’t elicit any response until press time Sunday.